IMPAX Laboratories, Inc. Launches Oxymorphone Hydrochloride Extended-Release Tablets

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it is commencing shipment of Oxymorphone Hydrochloride Extended-Release Tablets, through Global Pharmaceuticals, Impax’s generics division.

MORE ON THIS TOPIC